Course taster

Treatment options

Treatments and therapies to stop or slow neurodegenerative diseases are limited, although some forms of dementia are treatable (National Institute of Neurological Disorders and Stroke, 2014).

Many governments throughout the world have formulated strategies and have committed increased funding for research; support for those affected by dementia and their families; increased public awareness about dementia; and improved data collection and analysis to better understand the impact of dementia on people with the disease, their families, and the health and long-term care systems (National Institute of Neurological Disorders and Stroke, 2014).

One of the most exciting research studies is currently being conducted at University College, London, under the direction of Professor Cordeiro (2010). Her group's work is focused on the mechanisms of neurodegeneration and vision loss and is particularly related to the early diagnosis and management of age-related neurodegenerative processes. The main aim of this work is to identify early markers of cell processes in neurodegenerative disease in the eye (including glaucoma, Alzheimer's and Parkinson's) and to establish new methods of early diagnosis and treatment of these diseases - using the eye as a window to the brain (UCL, 2010) (Watch from 18:17 - 19:49).

Academic standing at podium giving a lecture

View Eyeing the brain video transcript